Selective lung or heart-lung transplantation for pulmonary hypertension associated with congenital cardiac anomalies.

Abstract

Fixed pulmonary hypertension has been a contraindication to correction of congenital heart defects. Beginning in February 1991, we pursued a policy of performing single-lung transplantation with intracardiac repair for selected patients with this physiology, reserving heart-lung transplantation for those with unreconstructable heart disease. Of 7 patients treated under this protocol, 5 underwent single-lung transplantation and intracardiac repair. The cardiac anomalies included complete atrioventricular canal (1), aortopulmonary window (1), atrial septal defect (1), and ventricular septal defect (2). One patient died perioperatively. All 4 patients surviving operation remained alive through the first postoperative year, but 3 died 13, 17, and 22 months after operation. Two other patients with pulmonary hypertension (1 with tricuspid atresia, 1 after failed Mustard procedure) received a heart-lung transplant and are well 15 and 18 months after operation. This experience demonstrates that selected patients with major intracardiac defects and pulmonary hypertension may have good early results after cardiac repair and single-lung transplantation, but that long-term results are considerably less favorable.

• Authors: F M Lupinetti, S F Bolling, E L Bove, L A Brunsting 3rd, D C Crowley, J P Lynch, M B Orringer, R I Whyte, G M Deeb
• Journal: The Annals of thoracic surgery (Ann Thorac Surg) Vol. 57 Issue 6 Pg. 1545-8; discussio 1549 (Jun 1994) ISSN: 0003-4975 [Print] Netherlands
• PMID: 8010800 (Publication Type: Journal Article)

Chemical References

• Immunosuppressive Agents

Topics

• Adolescent
• Adult
• Cause of Death
• Female
• Graft Rejection (etiology)
• Heart Defects, Congenital (complications, surgery)
• Heart Septal Defects (complications, surgery)
• Heart-Lung Transplantation (adverse effects, methods)
• Humans
• Hypertension, Pulmonary (complications, surgery)
• Immunosuppressive Agents (therapeutic use)
• Lung Transplantation (adverse effects, methods)
• Male
• Middle Aged
• Mycoses (etiology)
• Pneumonia (microbiology)
• Sternum (surgery)
• Surgical Wound Infection (etiology)
• Survival Rate
• Thoracotomy (methods)